D2B3: Funding, Investors & Team (Oct 2026)
D2B3 is a new biotechnology startup that focuses on developing creative ways to deliver drugs to the brain and central nervous system before clinical trials.
D2B3 has raised $500k across 1 funding round on record, the most recent a Pre-Seed of $500k announced in Apr 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
D2B3 Company Profile and Key Stats
Latest funding round on record: Apr 2025.
D2B3 Funding Rounds
D2B3 Founders and Leadership Team
No contact details are on record for this team yet.
D2B3 Funding Compared to Other Biotechnology Startups
D2B3's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like D2B3 in Biotechnology and New Haven
Companies Similar to D2B3
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
D2B3 Funding FAQs
What does D2B3 do?
D2B3 is a new biotechnology startup that focuses on developing creative ways to deliver drugs to the brain and central nervous system before clinical trials.
How much funding has D2B3 raised?
D2B3 has raised $500k across 1 round on record. The most recent is a Pre-Seed of $500k announced in Apr 2025.
When did D2B3 last raise funding?
D2B3's most recent funding round on record is a Pre-Seed of $500k, announced in Apr 2025.
Who founded D2B3?
FundedIQ lists Kevin Boye (Founder) at D2B3.
Where is D2B3 headquartered?
D2B3 is based in New Haven, Connecticut, United States.
How many employees does D2B3 have?
D2B3 is in the 1-10 employee band.
How does D2B3's funding compare to other Biotechnology startups?
D2B3's latest round of $500k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's D2B3 Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for D2B3 is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.